|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
G
GABA (gamma amino butyric acid), 1997, Vol. 11(4) pp. 7; 1998, Vol. 12(4) pp. 6; 2001, Vol. 15(4) pp. 2; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(2) pp. 2.
gabapentin, 1993, Vol. 07(4) pp. 5
GABRB 1989, Vol. 03(1) pp. 6
Gaby, Alan R., 1991, Vol. 05(1) pp. 5; 1994, Vol. 08(4) pp. 2; 1995, Vol. 09(3) pp. 3; 1996, Vol. 10(3) pp. 3.
Gaffney, Gary R., 1988, Vol. 02(2) pp. 7; 1989, Vol. 03(2) pp. 4; 1990, Vol. 04(1) pp. 4.
galactose, 2002, Vol. 16(2) pp. 4
galanin, 2003, Vol. 17(3) pp. 4
galantamine (Reminyl), 2002, Vol. 16(4) pp. 5
Gale, James, 1995, Vol. 09(1) pp. 7
gallic acid, 1995, Vol. 09(4) pp. 6
Gallup, Ray, 1999, Vol. 13(2) pp. 7; 2003, Vol. 17(1) pp. 7.
gamma-amino butyric acid, 1997, Vol. 11(4) pp. 7; 1998, Vol. 12(4) pp. 6; 2001, Vol. 15(4) pp. 2; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(2) pp. 2.
gamma-amino butyric acid receptor beta3-subunit (GABRB3 ), 2003, Vol. 17(1) pp. 6
Ganguli, Rohan, 1999, Vol. 13(3) pp. 2
Garand, Joy D., 1993, Vol. 07(2) pp. 5
"garbage science," 2000, Vol. 14(4) pp. 3
Garber, Malcolm, 1991, Vol. 05(4) pp. 7
Garcia, David, 2001, Vol. 15(2) pp. 5
Gardner, Richard, 1993, Vol. 07(2) pp. 6
Garrety, Andrew, 1999, Vol. 13(3) pp. 2
Gastault, Henri, 1987, Vol. 01(3) pp. 2
gastritis, 2001, Vol. 15(4) pp. 2
gastrointestinal symptoms
and aggression, 2001, Vol. 15(4) pp. 3
Bechanecol for, 2000, Vol. 14(1) pp. 6
bleeding and SSRIs, 1999, Vol. 13(4) pp. 4
constipation, 2003, Vol. 17(1) pp. 6; 2003, Vol. 17(4) pp. 5.
enterocolitis, 2001, Vol. 15(4) pp. 2
esophagitis, 2001, Vol. 15(2) pp. 6; 2001, Vol. 15(4) pp. 2.
gastritis, 2001, Vol. 15(4) pp. 2
and glutathione deficiency, 2004, Vol. 18(4) pp. 1
ileocolitis, 2002, Vol. 16(2) pp. 1
lymphoid nodular hyperplasia, 2001, Vol. 15(4) pp. 2; 2004, Vol. 18(3) pp. 7.
megarectum, 2003, Vol. 17(4) pp. 5
in metallothionein disorder, 2001, Vol. 15(2) pp. 4
Pepcid for, 2001, Vol. 15(2) pp. 6
secretin for, 1999, Vol. 13(4) pp. 7; 2000, Vol. 14(1) pp. 7; 2000, Vol. 14(3) pp. 6; 2002, Vol. 16(3) pp. 2.
and self-injuring behaviors, 2001, Vol. 15(4) pp. 3
and vaccines, 1998, Vol. 12(1) pp. 1; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(3) pp. 1.
gastrointestinal symptomss, 2000, Vol. 14(4) pp. 2
gastrostomy, 1995, Vol. 09(4) pp. 7
GATE Pharmaceuticals, 2000, Vol. 14(1) pp. 4
Gauthier, Isabel, 2000, Vol. 14(2) pp. 6
Gaydos, Alexa M., 2001, Vol. 15(2) pp. 5
Gaylord-Ross, Robert, 1990, Vol. 04(3) pp. 2
gaze monitoring, 1996, Vol. 10(2) pp. 6; 2003, Vol. 17(2) pp. 6.
Gebre-Mariam, Ayele, 1988, Vol. 02(2) pp. 7
Gedye, A.
buspirone for aggression, 1991, Vol. 05(4) pp. 4; 1996, Vol. 10(1) pp. 4.
self-injury as temporal lobe seizures, 1993, Vol. 07(1) pp. 4; 1995, Vol. 09(4) pp. 3.
serotonin diet for self-injury, 2002, Vol. 16(2) pp. 7
Tourette's and autism as seizure disorders, 1992, Vol. 06(1) pp. 4
Trazadone for self-injury, 1992, Vol. 06(1) pp. 5; 2002, Vol. 16(2) pp. 7.
Geier, David A. and Mark R.
Geller, Edward, 1987, Vol. 01(3) pp. 2
Genazzani, Andrea R., 1987, Vol. 01(2) pp. 6; 1988, Vol. 02(3) pp. 4; 1989, Vol. 03(3) pp. 7.
gender differences
in antioxidant capacities, 2004, Vol. 18(4) pp. 1
in creatine transporter gene defects, 2003, Vol. 17(3) pp. 4
in empathizing skills, 2002, Vol. 16(3) pp. 6
and environmental responsiveness of females, 2002, Vol. 16(2) pp. 4
in HUFA (highly unsaturated fatty acids) need, 2000, Vol. 14(4) pp. 6
in inflammatory bowel disease, 2002, Vol. 16(1) pp. 1
in systematizing skills, 2002, Vol. 16(3) pp. 6
in Tarvil's effectiveness, 2003, Vol. 17(3) pp. 6
in thimerosol risk, 2003, Vol. 17(2) pp. 2
and X chromosome imprinting, 2001, Vol. 15(1) pp. 5
gender specific disorders
and autoimmune disorders, 1993, Vol. 07(1) pp. 5
and autosomal ones compared, 1987, Vol. 01(2) pp. 4
Fragile X, 1999, Vol. 13(1) pp. 6
Rett Syndrome (See Rett Syndrome)
speech loss prognosis, 1987, Vol. 01(4) pp. 6
tetanus infections, 1998, Vol. 12(4) pp. 1
gene mapping, 1989, Vol. 03(2) pp. 6
gene therapy, 2003, Vol. 17(3) pp. 4
genetic factors
aborted fetal cell lines, 2003, Vol. 17(3) pp. 7
ADA (adenosine deaminase) variants in purine metabolism, 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(2) pp. 2.
adenylosuccinate lyase (ADSL) deficiency and autism link, 1987, Vol. 01(2) pp. 1; 1996, Vol. 10(2) pp. 4; 2001, Vol. 15(1) pp. 7.
affective disorders in autistics' families, 1999, Vol. 13(2) pp. 2
alcoholism in autistics' family members, 2000, Vol. 14(1) pp. 4
ALS (amyotropic lateral sclerosis), 1995, Vol. 09(2) pp. 4
aneuploidy of the oocytes, 2003, Vol. 17(2) pp. 6
arginine repetition in Fragile X, 1991, Vol. 05(2) pp. 1
in Ashkenazi Jews, 1995, Vol. 09(2) pp. 4
in Asperger's, 1988, Vol. 02(4) pp. 7; 1989, Vol. 03(1) pp. 4; 2000, Vol. 14(4) pp. 5.
in autism and other disorders, 1988, Vol. 02(1) pp. 1
autosomal models of autism, 1989, Vol. 03(2) pp. 2; 1997, Vol. 11(2) pp. 3.
B44-DR 1990, Vol. 04(4) pp. 2
beta-2-adrenergic (B2AR) gene, 2004, Vol. 18(4) pp. 7
from bisphenol A (BPA), 2003, Vol. 17(2) pp. 6
brain damage as catalyst from eccentric to autistic, 1996, Vol. 10(3) pp. 2
C4B null allele, 1996, Vol. 10(4) pp. 2
cerebellar abnormalities, 1990, Vol. 04(1) pp. 4
chromosome 2, 1987, Vol. 01(1) pp. 4; 1998, Vol. 12(1) pp. 4; 1999, Vol. 13(3) pp. 5; 2001, Vol. 15(3) pp. 2; 2002, Vol. 16(2) pp. 5; 2004, Vol. 18(2) pp. 4.
chromosome 3, 2002, Vol. 16(2) pp. 5
chromosome 6, 2000, Vol. 14(1) pp. 2
chromosome 7, 1999, Vol. 13(2) pp. 2; 2000, Vol. 14(1) pp. 1; 2000, Vol. 14(3) pp. 7; 2001, Vol. 15(2) pp. 2; 2001, Vol. 15(3) pp. 2; 2002, Vol. 16(2) pp. 5.
chromosome 9, 1989, Vol. 03(2) pp. 6
chromosome 11, 1992, Vol. 06(4) pp. 4
chromosome 13, 2000, Vol. 14(1) pp. 1–2
chromosome 15, 1990, Vol. 04(3) pp. 5; 1991, Vol. 05(4) pp. 4; 1994, Vol. 08(3) pp. 4; 1995, Vol. 09(2) pp. 4; 1997, Vol. 11(4) pp. 4; 1998, Vol. 12(3) pp. 4; 1999, Vol. 13(1) pp. 4; 1999, Vol. 13(2) pp. 2; 2000, Vol. 14(1) pp. 1; 2002, Vol. 16(2) pp. 5; 2003, Vol. 17(1) pp. 6; 2004, Vol. 18(4) pp. 6.
chromosome 16, 2000, Vol. 14(1) pp. 2; 2001, Vol. 15(3) pp. 2.
chromosome 17, 2001, Vol. 15(3) pp. 2
chromosome 18, 1999, Vol. 13(2) pp. 2
chromosome 19, 2002, Vol. 16(2) pp. 5
chromosome 20, 1998, Vol. 12(3) pp. 4
chromosome 21, 1995, Vol. 09(2) pp. 4
chromosome 22, 1998, Vol. 12(3) pp. 4
chromosome errors, 1996, Vol. 10(4) pp. 4; 2003, Vol. 17(2) pp. 6.
congenital adrenal hyperphasia, 1995, Vol. 09(1) pp. 7
creatine transporter gene defect, 2003, Vol. 17(3) pp. 4
dopamine allele, 1992, Vol. 06(2) pp. 4
dopamine beta-hydroxylase (DBH) gene, 2001, Vol. 15(2) pp. 2
"dose effect" in family members with autoimmune disease, 1997, Vol. 11(4) pp. 5
DPP IV (dipeptidyl peptidase IV) gene, 2002, Vol. 16(2) pp. 4
endothelin-3 gene in Waardenburg-Shah syndrome, 2001, Vol. 15(2) pp. 6
"engineering" genes in autism, 1997, Vol. 11(4) pp. 6
epigenetics, 2004, Vol. 18(4) pp. 6
family studies, 1989, Vol. 03(2) pp. 2; 1993, Vol. 07(2) pp. 2; 1999, Vol. 13(1) pp. 6; 2000, Vol. 14(1) pp. 4.
fingerprint abnormalities, 1990, Vol. 04(2) pp. 4
FMR1 gene, 1995, Vol. 09(3) pp. 1; 2001, Vol. 15(2) pp. 4; 2001, Vol. 15(3) pp. 4.
Fragile X (See Fragile X)
Friendship Interview, 1995, Vol. 09(4) pp. 4
gender differences, 2000, Vol. 14(4) pp. 6; 2001, Vol. 15(1) pp. 5; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(2) pp. 4.
gene mapping, 1989, Vol. 03(2) pp. 2
"good" gene excess, 1993, Vol. 07(1) pp. 5
and heavy metal excretion, 2002, Vol. 16(2) pp. 3
HLAs' role in fetal damage, 1987, Vol. 01(2) pp. 2
HOXA1, 1997, Vol. 11(3) pp. 1; 2000, Vol. 14(4) pp. 5.
HOXB1, 2000, Vol. 14(4) pp. 5
HRAS on chromosome 11 and autism, 1992, Vol. 06(4) pp. 4
imprinting, 1991, Vol. 05(2) pp. 2; 1997, Vol. 11(4) pp. 4; 2001, Vol. 15(1) pp. 5.
and landfill proximity, 2002, Vol. 16(1) pp. 4
Leominster autism cases, 1992, Vol. 06(2) pp. 1
limbic abnormalities, 1990, Vol. 04(1) pp. 4
lyase deficiency, 1987, Vol. 01(2) pp. 1
major histocompatibility complex (MHC), 1996, Vol. 10(4) pp. 2
male hormones on female fetuses, 1995, Vol. 09(1) pp. 7
MeCP2 mutation in Rett's, 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(1) pp. 5; 2001, Vol. 15(2) pp. 5.
mitochondrial defects in Rett's syndrome, 1991, Vol. 05(2) pp. 4
neuropathy target esterase (NTE), 2003, Vol. 17(1) pp. 6
and obstetric complications compared, 1995, Vol. 09(1) pp. 2
as overemphasized in funding, 1997, Vol. 11(2) pp. 3
in Parkinson's, 2001, Vol. 15(3) pp. 7; 2002, Vol. 16(3) pp. 4.
in PDD and related disorders, 1999, Vol. 13(1) pp. 6
perfect pitch in autistics, 2003, Vol. 17(4) pp. 4
physical characteristics, 1999, Vol. 13(3) pp. 5
population studies, 1989, Vol. 03(2) pp. 2; 1991, Vol. 05(2) pp. 4.
reelin gene variant, 2001, Vol. 15(2) pp. 1
and reproductive decisions, 1989, Vol. 03(2) pp. 2
retinoblastoma, 1989, Vol. 03(1) pp. 4
in Rett Syndrome, 1987, Vol. 01(2) pp. 6; 1988, Vol. 02(4) pp. 4; 1989, Vol. 03(1) pp. 4; 1991, Vol. 05(2) pp. 4; 1996, Vol. 10(1) pp. 2; 1999, Vol. 13(1) pp. 6; 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(1) pp. 5.
Rimland's research on autism and, 1997, Vol. 11(2) pp. 3
savant skills, 1989, Vol. 03(1) pp. 7
schizophrenia and autism, 1995, Vol. 09(2) pp. 4
serotonin, 1994, Vol. 08(3) pp. 4; 1997, Vol. 11(2) pp. 2; 1997, Vol. 11(4) pp. 2.
in siblings, 1991, Vol. 05(3) pp. 6; 1997, Vol. 11(2) pp. 4.
in specific language impairment (SLI) and autism, 2000, Vol. 14(3) pp. 7
and strep infection, 1996, Vol. 10(3) pp. 1
subtypes of autism, 1991, Vol. 05(4) pp. 4; 1993, Vol. 07(2) pp. 3.
in Tay Sachs, 1995, Vol. 09(2) pp. 4
thimerosol and, 2003, Vol. 17(1) pp. 2
tic disorders, 1996, Vol. 10(3) pp. 1
in Tourette's, 1991, Vol. 05(3) pp. 1
trinucleotide sequence abnormalities, 1996, Vol. 10(4) pp. 5; 2001, Vol. 15(4) pp. 6.
trisomy 21, 1993, Vol. 07(2) pp. 4
tuberous sclerosis, 1987, Vol. 01(2) pp. 4; 1989, Vol. 03(2) pp. 6; 1993, Vol. 07(3) pp. 4; 1995, Vol. 09(4) pp. 3; 1996, Vol. 10(2) pp. 7; 1996, Vol. 10(3) pp. 5; 1997, Vol. 11(1) pp. 4; 2001, Vol. 15(4) pp. 4.
Turner's syndrome, 2001, Vol. 15(1) pp. 5
twin studies, 1989, Vol. 03(2) pp. 1; 1997, Vol. 11(2) pp. 4.
twinning in autistics' families, 2001, Vol. 15(4) pp. 5
WNT2 gene, 2001, Vol. 15(2) pp. 2
X chromosome, 1987, Vol. 01(2) pp. 4; 1989, Vol. 03(2) pp. 2; 1989, Vol. 03(4) pp. 4; 1996, Vol. 10(1) pp. 2; 1996, Vol. 10(4) pp. 5; 1999, Vol. 13(1) pp. 6; 1999, Vol. 13(3) pp. 5; 2001, Vol. 15(1) pp. 5; 2001, Vol. 15(3) pp. 7; 2002, Vol. 16(2) pp. 5; 2002, Vol. 16(3) pp. 4; 2003, Vol. 17(3) pp. 4.
X-linked MECP2 protein mutation in Rett's syndrome, 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(1) pp. 5; 2001, Vol. 15(2) pp. 5.
XYY, 1988, Vol. 02(1) pp. 2; 1991, Vol. 05(3) pp. 4.
Y chromosome, 1987, Vol. 01(2) pp. 4; 1989, Vol. 03(2) pp. 2; 1989, Vol. 03(4) pp. 4; 1996, Vol. 10(1) pp. 2; 1996, Vol. 10(4) pp. 5; 1998, Vol. 12(4) pp. 4; 2002, Vol. 16(2) pp. 5.
Gentle Reminder beeper cue, 1999, Vol. 13(2) pp. 5
Gentle Teaching, 1989, Vol. 03(3) pp. 1; 1995, Vol. 09(1) pp. 6.
Geodon (ziprasidone), 2003, Vol. 17(3) pp. 2
George, Mark S., 1992, Vol. 06(4) pp. 4
Georgiana Foundation (for AIT practitioners), 1992, Vol. 06(2) pp. 2
Georgie (in The Sound of a Miracle), 1991, Vol. 05(3) pp. 1
Gepner, Bruno, 1995, Vol. 09(4) pp. 5
Gerberding, Julie, 2004, Vol. 18(2) pp. 6
Gerhardt, Peter, 1988, Vol. 02(3) pp. 2
gestural recognition, 2001, Vol. 15(3) pp. 4
GFA (glial fibrillary acidic protein), 1994, Vol. 08(1) pp. 4
Ghaziuddin, Mohammad, 1991, Vol. 05(4) pp. 1; 1993, Vol. 07(2) pp. 4; 1995, Vol. 09(2) pp. 6; 1999, Vol. 13(3) pp. 5.
Gianfrancesco, F. D., 2002, Vol. 16(4) pp. 6
Giangiabbe, Rose, 1994, Vol. 08(3) pp. 6
Gibbs, Lynn, 1996, Vol. 10(3) pp. 7
Gibbs, Zachary, 1996, Vol. 10(3) pp. 7
Giddan, Jane J., 1993, Vol. 07(2) pp. 2
Giddan, Norman S., 1993, Vol. 07(2) pp. 2
gifted autistics, education of, 1995, Vol. 09(2) pp. 5
Gilbert-Oakley, Kimberlie, 1995, Vol. 09(3) pp. 6; 1995, Vol. 09(4) pp. 2; 1996, Vol. 10(4) pp. 6.
Gillberg, Christopher
on Asperger's, 1988, Vol. 02(4) pp. 7; 1990, Vol. 04(3) pp. 4.
autism and other disorders, 1988, Vol. 02(1) pp. 1; 1996, Vol. 10(3) pp. 5.
autism subtype, 1991, Vol. 05(4) pp. 4
The Biology of the Autistic Syndromes (book), 1993, Vol. 07(2) pp. 7
CHAT (Checklist for Autism in Toddlers), 1993, Vol. 07(1) pp. 1
dopamine findings, 1987, Vol. 01(4) pp. 4
Down's syndrome and autism co-occurrence, 1993, Vol. 07(2) pp. 4
Fragile X twin girls' finding, 1989, Vol. 03(2) pp. 6
hypomelanosis of Ito study, 1992, Vol. 06(1) pp. 4
on March birthdays, 1991, Vol. 05(1) pp. 5
Moebius syndrome and autism linked, 1989, Vol. 03(4) pp. 4
on pain threshold, 1994, Vol. 08(3) pp. 2
population study, 1989, Vol. 03(2) pp. 1
seizures and autism, 1996, Vol. 10(2) pp. 7
stereotypies and brain opioids, 1987, Vol. 01(4) pp. 4
Williams syndrome and autism combined, 1994, Vol. 08(2) pp. 4; 2001, Vol. 15(4) pp. 4.
Gillberg, I. Carina, 1990, Vol. 04(3) pp. 4; 1992, Vol. 06(2) pp. 7.
Gimson, Karen, 1992, Vol. 06(1) pp. 6
Gladue, Brian, 1994, Vol. 08(3) pp. 7
Glascoe, Frances Page, 1997, Vol. 11(2) pp. 5
glasses. See eyeglasses
Glasson, Emma, 2002, Vol. 16(4) pp. 2
gliadin, 2003, Vol. 17(4) pp. 4
glial cells, 1987, Vol. 01(1) pp. 1
glial fibrillary acidic protein (GFA), 1994, Vol. 08(1) pp. 4
Glickenberger, Maureen, 2001, Vol. 15(3) pp. 6
"global form" test, 2003, Vol. 17(2) pp. 6
Glovak, Sandy, 1995, Vol. 09(3) pp. 6–7
glutamate, 2003, Vol. 17(2) pp. 2; 2004, Vol. 18(2) pp. 2.
glutamine, 2001, Vol. 15(4) pp. 2
glutaric acid analysis, 1998, Vol. 12(3) pp. 2
glutathione, 2003, Vol. 17(1) pp. 2; 2004, Vol. 18(4) pp. 1.
gluten, 1993, Vol. 07(1) pp. 4; 1999, Vol. 13(2) pp. 6; 2000, Vol. 14(1) pp. 6; 2000, Vol. 14(2) pp. 2.
gluten-free diet
for agitation, 2002, Vol. 16(3) pp. 1
for attention, 1999, Vol. 13(2) pp. 6
for autistic symptoms, 1999, Vol. 13(2) pp. 1; 2001, Vol. 15(1) pp. 6; 2001, Vol. 15(3) pp. 4; 2002, Vol. 16(3) pp. 1; 2004, Vol. 18(4) pp. 2.
celiac information, 1995, Vol. 09(3) pp. 7; 1996, Vol. 10(3) pp. 7.
in DAN! Protocol, 1997, Vol. 11(1) pp. 6
enzymes for, 2002, Vol. 16(1) pp. 3; 2002, Vol. 16(2) pp. 4.
eosinophils lowered during, 2003, Vol. 17(4) pp. 1
paper by Lisa Lewis, 1994, Vol. 08(3) pp. 7
for peptidase deficiencies, 1991, Vol. 05(4) pp. 2; 1992, Vol. 06(1) pp. 7; 1993, Vol. 07(1) pp. 4; 1995, Vol. 09(4) pp. 5.
for perseveration, 1997, Vol. 11(1) pp. 6
and phenol intolerance, 1995, Vol. 09(4) pp. 6
and Specific Carbohydrate Diet, 2004, Vol. 18(4) pp. 2
website for, 2002, Vol. 16(1) pp. 3
for weight gain, 1993, Vol. 07(4) pp. 6
Gobbi, Giuseppe, 1993, Vol. 07(1) pp. 4
Goetz, Lori, 1989, Vol. 03(3) pp. 5
Goh, Han-Leong, 1999, Vol. 13(4) pp. 5
Golan, Ofer, 2003, Vol. 17(2) pp. 5
Gold, Joan, 1989, Vol. 03(1) pp. 6
Gold, M. W., 1990, Vol. 04(3) pp. 1
Gold, Nora, 1991, Vol. 05(3) pp. 6
Gold, Phyllis-Terri, 1990, Vol. 04(2) pp. 1
Goldblatt, Alan, 2004, Vol. 18(3) pp. 3
Goldenberg, Cindy, 1995, Vol. 09(2) pp. 7; 1996, Vol. 10(1) pp. 3.
Goldman, Gary S., 2004, Vol. 18(3) pp. 1
Goode, Stephen, 1995, Vol. 09(4) pp. 1
Goodman, Ann B., 1995, Vol. 09(2) pp. 4
Goodman, Joan, 1989, Vol. 03(1) pp. 3; 1989, Vol. 03(4) pp. 2.
Goodman, Robert, 1991, Vol. 05(1) pp. 5
Goodwin, Mary, 1988, Vol. 02(1) pp. 3; 1994, Vol. 08(4) pp. 3.
Gordon, Charles T., 1992, Vol. 06(2) pp. 7; 1993, Vol. 07(3) pp. 1; 1996, Vol. 10(3) pp. 6; 1996, Vol. 10(4) pp. 4.
Gorman, Brian J., 2000, Vol. 14(2) pp. 5
Gorman-Smith, Deborah, 1988, Vol. 02(3) pp. 1
Gottschall, Elaine, 2004, Vol. 18(3) pp. 3; 2004, Vol. 18(4) pp. 2.
Government Reform, U. S. House Committee on, 2003, Vol. 17(2) pp. 1–2
Grace, Nancy, 1988, Vol. 02(4) pp. 5
Graham, David, 1987, Vol. 01(3) pp. 3
Grandin, Temple
channeling fixations, 1987, Vol. 01(2) pp. 5; 1990, Vol. 04(3) pp. 6.
on drug dosages, 1991, Vol. 05(4) pp. 1
on holding, 1987, Vol. 01(3) pp. 3; 1987, Vol. 01(4) pp. 2; 1990, Vol. 04(4) pp. 5.
on sensory stimulation, 1988, Vol. 02(4) pp. 6; 1991, Vol. 05(2) pp. 3; 1995, Vol. 09(2) pp. 5.
on sound sensitivity, 1990, Vol. 04(4) pp. 3
Granpeesheh, Doreen, 2000, Vol. 14(1) pp. 7; 2004, Vol. 18(3) pp. 3.
granule cells, 1987, Vol. 01(1) pp. 1
grapefruit juice and drugs, 1997, Vol. 11(3) pp. 6
Gray, Carol A., 1993, Vol. 07(2) pp. 5
Gray, David, 1989, Vol. 03(4) pp. 1
Gray, David E., 1993, Vol. 07(3) pp. 5
Greco, C. M., 2002, Vol. 16(3) pp. 4
Green, Gina, 1992, Vol. 06(3) pp. 7; 1992, Vol. 06(4) pp. 2; 1993, Vol. 07(1) pp. 3; 1993, Vol. 07(2) pp. 7; 2002, Vol. 16(2) pp. 2; 2003, Vol. 17(3) pp. 1.
green tea, 2002, Vol. 16(4) pp. 5
Greenberg, D. A., 2001, Vol. 15(4) pp. 5
Greenberg, Roger P., 1993, Vol. 07(4) pp. 4
Greenspan, Stanley, 2003, Vol. 17(2) pp. 5
Gregg, Judd (U.S. Senate), 2004, Vol. 18(4) pp. 3
Gresham, Frank, 1998, Vol. 12(1) pp. 2; 1998, Vol. 12(3) pp. 7; 1999, Vol. 13(4) pp. 1.
Grice, H. P., 1990, Vol. 04(2) pp. 2
Grieco, Paulo, 2003, Vol. 17(1) pp. 7
Griffith, H.W., 1997, Vol. 11(2) pp. 7
Griffiths, Paul D., 1997, Vol. 11(1) pp. 4
grocery shopping, 1987, Vol. 01(4) pp. 5; 1993, Vol. 07(4) pp. 5.
Groden, Gerald, 1987, Vol. 01(3) pp. 2
Groden, June, 1988, Vol. 02(4) pp. 5
group homes. See also deinstitutionalization
American Dietetic Association on diets in, 1993, Vol. 07(2) pp. 2
criteria for, 1995, Vol. 09(4) pp. 6–7
and institutions compared, 1995, Vol. 09(3) pp. 1
investigations, 1993, Vol. 07(2) pp. 1–2
monitoring necessary, 1991, Vol. 05(3) pp. 3
moratorium needed, 1997, Vol. 11(2) pp. 6
mortality rate in, 1996, Vol. 10(4) pp. 1; 1997, Vol. 11(1) pp. 3; 1997, Vol. 11(2) pp. 6.
nutrition studies, 1993, Vol. 07(2) pp. 2
training for service providers, 1993, Vol. 07(2) pp. 5
growth factors, 1989, Vol. 03(3) pp. 7; 2001, Vol. 15(4) pp. 4.
growth regulators, 1989, Vol. 03(3) pp. 7
Gruber, Harry, 1987, Vol. 01(2) pp. 1; 2001, Vol. 15(1) pp. 7.
Gruber, Staci, 2004, Vol. 18(2) pp. 2
"GS" guinea pigs, 1998, Vol. 12(4) pp. 4
GSH (glutathione), 2004, Vol. 18(4) pp. 1. See also glutathione
Gualtieri, C. Thomas, 1987, Vol. 01(3) pp. 1; 1987, Vol. 01(4) pp. 3; 1993, Vol. 07(1) pp. 4.
guinea pigs, 1998, Vol. 12(4) pp. 4
Gulf War syndrome, 2003, Vol. 17(1) pp. 6
Gupta, Sudhir, 1996, Vol. 10(1) pp. 1; 1996, Vol. 10(3) pp. 1; 1997, Vol. 11(1) pp. 1; 1997, Vol. 11(2) pp. 7; 1998, Vol. 12(2) pp. 1; 1998, Vol. 12(4) pp. 1; 2002, Vol. 16(3) pp. 1.
Gurrieri, F., 1999, Vol. 13(2) pp. 4
gut and brain connection. See brain and gut connection
gut epithelial dysfunction, 2001, Vol. 15(1) pp. 1; 2002, Vol. 16(2) pp. 1.
© copyright 2005, 2006 Autism Research Institute
|
|
